ReviewClinical pharmacology and therapeutics2019

Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.

Neeraj Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.